LOSARTAN VS ATENOLOL IN HYPERTENSIVES WITH LEFT VENTRICULAR HYPERTROPHY

氯沙坦与阿替洛尔治疗高血压伴左心室肥大的比较

• 批准号: 6304852
• 负责人: BRADLEY G PHILLIPS
• 金额: $ 2.2万
• 依托单位: UNIVERSITY OF IOWA
• 依托单位国家: 美国
• 财政年份: 1999
• 资助国家: 美国
• 起止时间: 1999-12-01 至 2000-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6304852
• 关键词: atenolol; cardiovascular function; clinical research; drug screening /evaluation; human morbidity; human mortality; human subject; hypertension; losartan; ventricular hypertrophy

This study is evaluating the long-term effects of losartan compared to atenolol in hypertensive patients with documented left ventricular hypertrophy on the combination of cardiovascular mortality and morbidity.

本研究旨在评价氯沙坦与阿替洛尔相比，在有记录的左心室肥厚的高血压患者中对心血管死亡率和发病率的长期影响。